Melanoma patient characteristics of the OS cohort
(n = 104) | |
---|---|
Clinical characteristics | |
Gender, n (%) | |
Male | 75 (72.1) |
Female | 29 (27.9) |
Age, n (range) | |
Median | 74.5 (22–96) |
Location of tumor, n (%) | |
Trunk | 61 (58.7) |
Extremity | 41 (39.4) |
Unknown | 2 (1.9) |
Stage, n (%) | |
II | 91 (87.5) |
III | 13 (12.5) |
Pathologic characteristics | |
Depth (mm) | |
Median, n (range) | 2.5 (0.6–26) |
Ulceration, n (%) | |
Absent | 36 (34.6) |
Present | 65 (62.5) |
Unknown | 3 (2.9) |
TILs, n (%) | |
Absent | 2 (1.9) |
Non-brisk | 59 (56.8) |
Brisk | 33 (31.7) |
Unknown | 10 (9.6) |
Outcome characteristics | |
Patient follow-up (months) | |
Median, n (range) | 45 (4–173) |
OS (months) | |
Alive (at least 2 years), n (%) | 31 (29.8) |
Dead, n (%) | 73 (70.2) |
DSS (months) | |
Alive or NED at death, n (%) | 42 (40.4) |
Dead with melanoma, n (%) | 22 (21.2) |
Unknown, n (%) | 40 (38.4) |
Abbreviations: DSS, disease-specific survival; NED, no evidence of disease; TILs, tumor-infiltrating lymphocytes.